RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS

被引：0
|
作者：
KIRWAN, JR [1 ]
CURREY, HLF [1 ]
机构：
[1] LONDON HOSP, LONDON E1 1BB, ENGLAND
来源：
CLINICS IN RHEUMATIC DISEASES | 1983年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：581 / 599
页数：19
相关论文
共 50 条
  • [11] Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs
    Meroni, P. L.
    Zavaglia, D.
    Girmenia, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 317 - 328
  • [12] Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management
    Singh, Sukhbir
    Tiwary, Neha
    Sharma, Neelam
    Behl, Tapan
    Antil, Anita
    Anwer, Md. Khalid
    Ramniwas, Seema
    Sachdeva, Monika
    Elossaily, Gehan M.
    Gulati, Monica
    Ohja, Shreesh
    PHARMACEUTICALS, 2024, 17 (02)
  • [13] Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
    Giachi, Andrea
    Cugno, Massimo
    Gualtierotti, Roberta
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [14] Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Syngle, Ashit
    Kaur, Sudeep
    Verma, Inderjeet
    Syngle, Tanya
    Syngle, Vijaita
    CLINICAL RHEUMATOLOGY, 2017, 36 (08) : 1715 - 1720
  • [15] The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [16] Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Ashit Syngle
    Sudeep Kaur
    Inderjeet Verma
    Tanya Syngle
    Vijaita Syngle
    Clinical Rheumatology, 2017, 36 : 1715 - 1720
  • [17] Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?
    Scott, I. C.
    Kingsley, G. H.
    Scott, D. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S4 - S8
  • [18] Pharmacogenetics of disease-modifying anti-rheumatic drugs
    Tanaka, E
    Taniguchi, A
    Urano, W
    Yamanaka, H
    Kamatani, N
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
  • [19] Disease-modifying anti-rheumatic drugs - Cyclosporin
    Chaudhuri, K
    Torley, H
    Madhok, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
  • [20] Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
    Choy, Ernest H.
    RHEUMATOLOGY, 2019, 58 : 51 - 55
12345